Clinical Trial Update: Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for zilebesiran in adults with hypertension not adequately controlled and with established cardiovascular disease or high cardio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension

Drugs mentioned

• Zilebesiran

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: High Risk Cardiovascular Disease, Hypertension | Phase 3 | Status: RECRUITING